AfoninLab

Reimagining Personalized Medicine: Charlotte Researchers Develop Artificial Intelligence-Cell to Design Precision Interventions

More than 10 years in the making, researchers in the growing fields of bionanotechnology and artificial intelligence have combined forces to accurately predict – and ultimately influence – how the human immune system responds to next-generation therapeutics.

AI-Cell – which stands for Artificial Immune Cell or Artificial Intelligence Cell – is already in use, freely available to biomedical researchers who may use it in their first steps toward designing the next life-saving cancer treatment or vaccine to stave off worldwide illness.

The study of RNA has become one of the most prominent areas in modern biology and biomedicine. RNA is now appreciated to function as an enzyme, natural scaffold, and powerful regulator of gene expression. Our lab's mission is to develop novel functional RNA-based nanomaterials that can either (i) communicate with each other or with cellular machinery or (ii) be readily responsive to various stimuli. In the long term, our research aims at improving the operation of current therapeutic systems and engineering novel “smart” biomaterials.